Glycine transporter-inhibiting substances

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8796272
APP PUB NO 20130331571A1
SERIAL NO

14000261

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to novel compounds of formula [I] or pharmaceutically acceptable salts thereof:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TAISHO PHARMACEUTICAL CO LTDTOKYO 171

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Abe, Kumi Toshima-ku, JP 7 11
Araki, Yuko Toshima-ku, JP 12 66
Moriya, Minoru Toshima-ku, JP 21 99
Ohta, Hiroshi Toshima-ku, JP 180 2022
Sun, Xiang-Min Toshima-ku, JP 5 11
Wakasugi, Daisuke Toshima-ku, JP 6 20
Yamamoto, Shuji Toshima-ku, JP 72 669

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 5, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00